Related Experiment Video
Updated: Oct 9, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Transfusion thresholds for guiding red blood cell transfusion
Jeffrey L Carson1, Simon J Stanworth2,3,4, Jane A Dennis5
1Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
A restrictive red blood cell (RBC) transfusion strategy, using lower hemoglobin thresholds (7.0-8.0 g/dL), reduced RBC exposure by 41% without increasing 30-day mortality or other adverse outcomes. Further research is needed for specific patient subgroups.
Area of Science:
- Hematology
- Transfusion Medicine
- Clinical Research
Background:
- Optimal hemoglobin thresholds for red blood cell (RBC) transfusions are under investigation.
- Blood is a scarce resource, and transfusion safety varies globally.
- A restrictive transfusion policy could become the standard of care if it matches liberal policies in outcomes.
Purpose of the Study:
- To compare 30-day mortality and other clinical outcomes between restrictive and liberal RBC transfusion thresholds.
- To evaluate the impact of different hemoglobin concentration triggers for RBC transfusions across all clinical conditions.
Main Methods:
- Systematic review and meta-analysis of randomized controlled trials (RCTs).
- Searched multiple databases (CENTRAL, MEDLINE, Embase, etc.) up to November 2020.
- Included RCTs comparing restrictive (lower Hb threshold) vs. liberal (higher Hb threshold) transfusion strategies in adults and children (excluding neonates).
- Extracted data using Cochrane methods and pooled risk ratios using a random-effects model.
Main Results:
- 48 trials with 21,433 participants were included across various clinical contexts.
- Restrictive transfusion strategies reduced RBC transfusion risk by 41% (RR 0.59, 95% CI 0.53-0.66) with high heterogeneity.
- No significant increase or decrease in 30-day mortality (RR 0.99, 95% CI 0.86-1.15) or other assessed morbidities (cardiac events, MI, stroke, thromboembolism, infection) was observed.
- Evidence strength was lower for specific subgroups like myocardial infarction and hematological malignancies.
Conclusions:
- Restrictive transfusion strategies significantly decrease RBC exposure without adversely affecting 30-day mortality or major morbidities.
- Data remain insufficient to definitively assess safety in specific high-risk subgroups.
- While hemoglobin concentration is a common marker, it may not be optimal for all patients; further research on optimal thresholds and patient-specific markers is needed.
More Related Videos
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
10:32Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
Published on: August 24, 2015
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Rh Blood Group
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
The ABO Blood Group
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
Blood Types
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...